OTC · Medical - Devices

GN Store Nord A/S (GNNDY) Stock

$41.99 -1.40% OTC: GNNDY Healthcare

GN Store Nord A/S, established in 1869 and headquartered in Ballerup, Denmark, specializes in the creation, manufacturing, and distribution of advanced audio and video communication solutions. These products cater to medical, professional, and consumer sectors across Denmark, the rest of Europe, North America, and various international markets.

Valuation

MetricValue
Price$41.99
Market Cap$2.04B
P/E Ratio-35.71
P/B Ratio1.32
P/S Ratio0.89
EPS (TTM)$12.93
52-Week High$57.22
52-Week Low$39.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.55%
ROA-1.31%
ROCE4.74%
Gross Margin39.22%
Operating Margin7.51%
Net Margin-2.49%
Debt/Equity0.98
Current Ratio1.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.8B$18.7B$18.1B$18.0B$16.8B
Operating Profit$2.4B$1.1B$869.0M$1.9B$1.6B
Net Profit$1.8B$511.0M$228.0M$988.0M$653.0M
EPS$40.47$11.97$4.92$20.34$12.93
Op Margin15.2%6.0%4.8%10.3%9.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.6B$30.6B$30.6B$30.6B$29.2B
Total Liabilities$17.3B$23.8B$21.1B$19.8B$18.3B
Cash$6.2B$990.0M$2.2B$980.0M$1.1B
Borrowings$11.6B$16.3B$13.5B$11.5B$10.8B

Latest News

[Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Jun 17, 2026 Trading in GN Store Nord shares by board members, executives and associated persons GlobeNewswire · Jun 17, 2026 Interim Report Q1 2026: Navigating challenging markets in EMEA and taking actions to adjust the cost structure for future healthy margins GlobeNewswire · May 6, 2026 Guidance updated to reflect Hearing business being treated as discontinued operations GlobeNewswire · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.1B$627.0M$2.6B$2.7B$2.7B
Investing Cash Flow$-3.3B$-10.8B$-2.6B$-2.9B$-3.1B
Financing Cash Flow$-1.0B$1.7B$71.0M$-131.0M$-196.0M
Net Cash Flow$4.6B$-5.2B$1.2B$-1.2B$139.0M
Free Cash Flow$588.0M$-1.0B$1.2B$1.3B$1.1B

Valuation & Return Ratios

MetricValue
PEG Ratio0.24
EV / EBITDA6.95
FCF Yield19.09%
Quick Ratio0.69
Interest Coverage1.86
Return 1Y-8.96%
Return 3Y-44.84%
Return 5Y-84.64%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Captrust Financial Advisors302022-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALFRYAlfresa Holdings Corporation $13.55 +0.00% 10.09 $2.46B 3.10%
HAWPYHaw Par Corporation Limited $53.50 +0.00% 13.52 $2.96B 1.16%
MCRPFMicroPort Scientific Corp. $0.85 +0.00% 35.38 $1.63B 0.00%
OSSFFEmbla Medical hf. $4.15 +0.00% 17.40 $1.77B 0.00%
OSSUYEmbla Medical hf. $3.82 +0.00% 17.40 $1.62B 0.00%

About GN Store Nord A/S

GN Store Nord A/S, established in 1869 and headquartered in Ballerup, Denmark, specializes in the creation, manufacturing, and distribution of advanced audio and video communication solutions. These products cater to medical, professional, and consumer sectors across Denmark, the rest of Europe, North America, and various international markets. The company operates through two main divisions: GN Hearing and GN Audio. GN Hearing is dedicated to producing and selling hearing instruments and associated products. In contrast, GN Audio offers a range of professional and consumer products, including headsets, video cameras, and speakerphones. Its portfolio includes well-known brands such as ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy.

GN Store Nord A/S is headquartered in DK.

GN Store Nord A/S (GNNDY) stock trades at $41.99 with a market capitalization of $2.04B. The stock is valued at a price-to-earnings (P/E) ratio of -35.71, price-to-book of 1.32, price-to-sales of 0.89. Over the past 52 weeks the stock has ranged between $39.45 and $57.22, and currently trades 26.6% below its 52-week high.

On profitability, GN Store Nord A/S generates a return on equity (ROE) of -3.55%, return on capital employed of 4.74%, an operating margin of 7.51%, a net profit margin of -2.49%.

Official website: www.gn.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides